A covid booster shot for omicron Pharma giant Pfizer asks FDA to greenlight new omicron booster shots If approved the shot is likely to be ready by fall Read this story On Monday the drugmakers Pfizer and BioNTech announced that they ve asked the Food and Drug Administration to authorize an updated version of their COVID vaccine this one designed specifically to target the omicron subvariants that are dominant in the U S More than of cases are caused by the BA and BA subvariants which took off this summer but the vaccines being used were designed for the original coronavirus strain from several years ago Pfizer and BioNTech said they have submitted pre clinical data on vaccine efficacy to the FDA but did not share the data publicly The new bivalent booster meaning it s a mix of two versions of the vaccine will target both the original coronavirus strain and the BA and BA omicron subvariants Full story here 